Ambey Laboratories Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

24.95

18.69

17.75

17.75

4.89

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

40.90

2.32

-4.61

-9.18

-12.76

Loan funds

Secured loans

40.84

29.64

13.65

18.05

32.93

Unsecured loans

-

-

-

-

-

Total

106.69

50.66

26.79

26.62

25.07

Uses of funds

Fixed assets

Gross block

56.76

23.98

55.00

52.15

40.24

Less : revaluation reserve

10.50

10.50

10.50

10.50

-

Less : accumulated depreciation

33.64

-

29.78

27.06

24.39

Net block

12.62

13.48

14.72

14.59

15.85

Capital work-in-progress

15.66

3.84

-

-

0.95

Investments

-

0.78

0.60

-

-

Net current assets

Current assets, loans & advances

88.43

50.82

31.80

30.84

27.82

Less : current liabilities & provisions

10.02

18.25

20.33

18.81

19.55

Total net current assets

78.41

32.56

11.47

12.03

8.27

Miscellaneous expenses not written

-

-

-

-

-

Total

106.69

50.66

26.79

26.62

25.07

Notes:

Book value of unquoted investments

-

0.78

0.60

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

13.82

-

-

-

-

Number of equity sharesoutstanding (Lacs)

249.47

186.89

17.75

17.75

4.89